Salt CompositionYou Searched
Matalert 200 Tablet
Matias Healthcare Pvt. Ltd.
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Narcolepsy (Uncontrollable daytime sleepiness)
Customers also bought
More About Matalert
Benefits
In Narcolepsy (Uncontrollable daytime sleepiness)Narcolepsy is a sleep disorder that causes excessive daytime drowsiness. The affected person may experience excessive sleepiness, sleep paralysis, hallucinations, and in some cases episodes of cataplexy (partial or total loss of muscle control). Matalert 200 Tablet stimulates the brain and keeps you fully awake and alert. It also relieves these abnormal symptoms and regulates the sleep cycle. This restores normal sleeping habits and improves your quality of life. You will feel more energetic and will be able to perform better in your daily activities. It is also reported to improve cognitive functions, such as enhanced memory, problem-solving abilities, and mental clarity.
Side Effects
Side effects of Matalert Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Matalert Headache Nausea Nervousness Anxiety Dizziness Insomnia (difficulty in sleeping)Diarrhea Indigestion Back pain Runny nose
How to use
How to use Matalert Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Matalert 200 Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
How Matalert Tablet works Matalert 200 Tablet modulates the levels of chemical messengers in the brain and exerts a stimulant effect to reduce extreme sleepiness.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Matalert 200 Tablet .
Matalert 200 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Matalert 200 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Matalert 200 Tablet may cause side effects which could affect your ability to drive.Patients with abnormal levels of sleepiness who take modafinil should be advised that their level of wakefulness may not return to normal, so they should avoid driving.
Matalert 200 Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Matalert 200 Tablet may not be needed in these patients. Doctor consultation is advised.
Matalert 200 Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Matalert 200 Tablet may be needed. Doctor consultation is advised.
What if I forget to take it?
If you forget a dose of Matalert 200 Tablet , simply continue with your regular schedule and do not take a double dose.
Manufacturer Address
101-104 GCP Business centre opp. Memnagar fire station Vijay cross road Memnagar Ahmedabad-380014 India
References
Stahl SM, editor. Modafinil. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 453-56
Biaggioni I, Robertson D. Adrenoreceptor Agonists & Sympathomimetic Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 141, 145
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 933-34
Modafinil. South Ruislip, Middlesex: Aurobindo Pharma - Milpharm Ltd.; 2012
Modafinil. North Wales, PA: Teva Pharmaceuticals USA; 1998 (25 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (25 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
